Literature DB >> 1686068

Release of arachidonic acid by NMDA-receptor activation in the rat hippocampus.

L Pellerin1, L S Wolfe.   

Abstract

In hippocampal slices arachidonic acid released after NMDA post-synaptic receptor activation is thought to act as a retrograde trans-synaptic messenger which facilitates the pre-synaptic release of L-glutamate to be involved in the expression of long-term synaptic potentiation (LTP). We measured the mass amount of arachidonic acid released from hippocampal slices incubated under conditions which maintain the electrophysiological responsiveness of the slice. Melittin released arachidonic, oleic and docosahexaenoic acids by phospholipase A2 activation but not palmitic or stearic acids. Of greater interest L-glutamate, N-methyl-D-aspartate and incubation conditions known to induce LTP selectively and rapidly increased the release of arachidonic acid in amounts over basal levels of 200-300 ng/mg protein. This is the first direct determination of the mass amount of arachidonic acid released following NMDA receptor activation in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686068     DOI: 10.1007/bf00965841

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  31 in total

Review 1.  Lipoxygenase metabolites of arachidonic acid in neuronal transmembrane signalling.

Authors:  D Piomelli; P Greengard
Journal:  Trends Pharmacol Sci       Date:  1990-09       Impact factor: 14.819

2.  On the specific vaso-dilating and plain muscle stimulating substances from accessory genital glands in man and certain animals (prostaglandin and vesiglandin).

Authors:  U S von Euler
Journal:  J Physiol       Date:  1936-11-06       Impact factor: 5.182

3.  Presynaptic mechanism for long-term potentiation in the hippocampus.

Authors:  J M Bekkers; C F Stevens
Journal:  Nature       Date:  1990-08-23       Impact factor: 49.962

4.  Nordihydroguaiaretic acid blocks the synaptic component of long-term potentiation and the associated increases in release of glutamate and arachidonate: an in vivo study in the dentate gyrus of the rat.

Authors:  M A Lynch; M L Errington; T V Bliss
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

5.  Temporally distinct pre- and post-synaptic mechanisms maintain long-term potentiation.

Authors:  S N Davies; R A Lester; K G Reymann; G L Collingridge
Journal:  Nature       Date:  1989-04-06       Impact factor: 49.962

6.  Potassium channels in cardiac cells activated by arachidonic acid and phospholipids.

Authors:  D Kim; D E Clapham
Journal:  Science       Date:  1989-06-09       Impact factor: 47.728

7.  Arachidonic acid metabolites as intracellular modulators of the G protein-gated cardiac K+ channel.

Authors:  Y Kurachi; H Ito; T Sugimoto; T Shimizu; I Miki; M Ui
Journal:  Nature       Date:  1989-02-09       Impact factor: 49.962

8.  Products of heme-catalyzed transformation of the arachidonate derivative 12-HPETE open S-type K+ channels in Aplysia.

Authors:  F Belardetti; W B Campbell; J R Falck; G Demontis; M Rosolowsky
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

9.  Arachidonic acid increases inositol phospholipid metabolism and glutamate release in synaptosomes prepared from hippocampal tissue.

Authors:  M A Lynch; K L Voss
Journal:  J Neurochem       Date:  1990-07       Impact factor: 5.372

10.  1-ether-linked phosphoglycerides. Major endogenous sources of arachidonate in the human neutrophil.

Authors:  F H Chilton; T R Connell
Journal:  J Biol Chem       Date:  1988-04-15       Impact factor: 5.157

View more
  9 in total

Review 1.  Excitable membranes, lipid messengers, and immediate-early genes. Alteration of signal transduction in neuromodulation and neurotrauma.

Authors:  J P Doucet; N G Bazan
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

Review 2.  Low molecular weight phospholipases A2 in mammalian brain and neural cells: roles in functions and dysfunctions.

Authors:  Gianfrancesco Goracci; Monica Ferrini; Vincenza Nardicchi
Journal:  Mol Neurobiol       Date:  2010-03-19       Impact factor: 5.590

3.  Mitochondrial dysfunction and lipid peroxidation in rat frontal cortex by chronic NMDA administration can be partially prevented by lithium treatment.

Authors:  Helena K Kim; Cameron Isaacs-Trepanier; Nika Elmi; Stanley I Rapoport; Ana C Andreazza
Journal:  J Psychiatr Res       Date:  2016-02-06       Impact factor: 4.791

4.  Limonoids from Dictamnus dasycarpus protect against glutamate-induced toxicity in primary cultured rat cortical cells.

Authors:  Jeong Seon Yoon; Hyekyung Yang; Seung Hyun Kim; Sang Hyun Sung; Young Choong Kim
Journal:  J Mol Neurosci       Date:  2010-02-13       Impact factor: 3.444

Review 5.  Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.

Authors:  Evelin L Schaeffer; Orestes V Forlenza; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-10-14       Impact factor: 4.530

6.  Conditioning training and retrieval increase phospholipase A(2) activity in the cerebral cortex of rats.

Authors:  E L Schaeffer; L Zorrón Pu; D A M Gagliotti; W F Gattaz
Journal:  J Neural Transm (Vienna)       Date:  2008-11-04       Impact factor: 3.575

Review 7.  Intracellular- and extracellular-derived Ca(2+) influence phospholipase A(2)-mediated fatty acid release from brain phospholipids.

Authors:  Angelo O Rosa; Stanley I Rapoport
Journal:  Biochim Biophys Acta       Date:  2009-03-25

Review 8.  Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme.

Authors:  Evelin L Schaeffer; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-02-19       Impact factor: 4.530

9.  Voluntary running in young adult mice reduces anxiety-like behavior and increases the accumulation of bioactive lipids in the cerebral cortex.

Authors:  Iván J Santos-Soto; Nataliya Chorna; Néstor M Carballeira; José G Vélez-Bartolomei; Ana T Méndez-Merced; Anatoliy P Chornyy; Sandra Peña de Ortiz
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.